Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma

pVHL/HIF-Regulated CD70 Expression Is Associated with Infiltration of CD27+ Lymphocytes and Increased Serum Levels of Soluble CD27 in Clear Cell Renal Cell Carcinoma

(2015) M. Ruf et al.   CLINICAL CANCER RESEARCH

Soluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor Immunity

(2013) J. Huang et al.   JOURNAL OF IMMUNOLOGY

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

(2013) Alessandro Conti et al.   Biomed Research International

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

(2013) Stephen Ansell et al.   Journal for ImmunoTherapy of Cancer

Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-Reactive Lymphocytes in Clear Cell Renal Cell Carcinoma

(2012) Q. J. Wang et al.   CANCER RESEARCH

Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology

(2009) Martijn A. Nolte et al.   IMMUNOLOGICAL REVIEWS

CD70 as a therapeutic target in human malignancies

(2008) Iqbal S Grewal   EXPERT OPINION ON THERAPEUTIC TARGETS